SYS-CON MEDIA Authors: Yeshim Deniz, Doug Masi, Mat Mathews, Newswire, David Smith

News Feed Item

Covaris, Inc. Opens New Office in Europe

BRIGHTON, England, April 10, 2014 /PRNewswire/ -- Covaris, Inc., an innovator in the life science tools and the clinical diagnostic market spaces, announced today that its European subsidiary, Covaris Ltd, which is located in the United Kingdom, will commence operations on May 1, 2014.

Covaris Ltd has sales, service, and application representatives throughout Europe providing a high level of support for recently launched application kits such as truXTRAC™ for FFPE DNA extraction  and truChIP™ for Chromatin shearing. Covaris, known for its proprietary Adaptive Focused Acoustics™ (AFA) technology, will enhance delivery times by shipping consumables, including the new microTUBE LV™, which enables DNA fragmenting in volumes as low as 15µl, from its European distribution centre in Brighton, England.

Covaris Founder and CEO, Jim Laugharn adds: "As analytical technologies for the life sciences become more sophisticated, the need for precise, accurate, and high-quality sample preparation becomes a critical prerequisite.  By establishing a local presence with Covaris Ltd, we will be better positioned to serve our European customers by providing direct product, application, and customer support services."

Covaris, Ltd. will be managed locally by Dr. Adrian Palmer who joined Covaris in 2013 and brings 15 years' experience in scientific, customer support and commercial roles acquired at Roche, Sirigen (a BD company) and Lab 21.

About Covaris, Inc.

Covaris utilizes proprietary technologies including Adaptive Focused Acoustic (AFA) to enable advanced sample preparation and optimization of analytical results.  The patented AFA process focuses controlled, precise and accurate mechanical energy to biological and chemical samples.  The process is non-contact, isothermal, and rapid.  Leading diagnostic centers, universities and pharmaceutical companies worldwide are using Covaris systems for sample preparation for molecular testing.

For further information please contact Covaris Ltd. directly or see


SOURCE Covaris, Inc.

More Stories By PR Newswire

Copyright © 2007 PR Newswire. All rights reserved. Republication or redistribution of PRNewswire content is expressly prohibited without the prior written consent of PRNewswire. PRNewswire shall not be liable for any errors or delays in the content, or for any actions taken in reliance thereon.